D. E. Shaw & Co., Inc. Atara Biotherapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.23 - $1.74 $661,577 - $5 Million	-2,876,424 Reduced 73.56%	1,033,992 $527,000
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $618,865 - $1.01 Million	-438,912 Reduced 10.09%	3,910,416 $5.79 Million
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $179,281 - $363,343	119,521 Added 2.83%	4,349,328 $7 Million
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $1.95 Million - $3.81 Million	697,807 Added 19.76%	4,229,807 $12.3 Million
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $2.31 Million - $4.21 Million	812,100 Added 29.86%	3,532,000 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $5.85 Million - $17.9 Million	2,051,695 Added 307.05%	2,719,900 $10.3 Million
Q2 2022 Aug 15, 2022	BUY	$4.69 - $9.84 $24,603 - $51,620	5,246 Added 0.79%	668,205 $5.21 Million
Q1 2022 May 16, 2022	SELL	$8.44 - $16.89 $2.16 Million - $4.33 Million	-256,442 Reduced 27.89%	662,959 $6.16 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $1.29 Million - $1.74 Million	87,494 Added 10.52%	919,401 $14.5 Million
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $160,378 - $239,430	13,376 Added 1.63%	831,907 $14.9 Million
Q2 2021 Aug 16, 2021	BUY	$12.89 - $16.58 $1.75 Million - $2.25 Million	135,474 Added 19.83%	818,531 $12.7 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $1.03 Million - $1.52 Million	73,403 Added 12.04%	683,057 $9.81 Million
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $3.67 Million - $7.6 Million	289,751 Added 90.57%	609,654 $12 Million
Q3 2020 Nov 16, 2020	BUY	$11.92 - $15.87 $272,968 - $363,423	22,900 Added 7.71%	319,903 $4.15 Million
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $2.24 Million - $4.43 Million	297,003 New	297,003 $4.33 Million
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $314,012 - $389,716	-8,959 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$35.15 - $51.45 $326,297 - $477,610	-9,283 Reduced 50.89%	8,959 $329,000
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $328,356 - $882,000	18,242 New	18,242 $711,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account